Unaudited financial results (standalone and consolidated) for the quarter ended September 30, 2026.

November 05, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No. C/1, Dalal Street, Fort, G Block, Bandra - Kurla Complex, Mumbai – 400 001 Bandra (East), Mumbai 400 051 Scrip Code: 506414 Trading Symbol: FERMENTA Dear Sir, Sub: Outcome of Board Meeting and Unaudited Financial Results – pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’). We write to inform you that the Board of Directors of the Company, at its meeting held on November 05, 2026, has, inter alia, approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2026. We are also enclosing herewith the Limited Review Reports on the aforesaid results (Standalone and Consolidated) issued by M/s. SRBC & Co. LLP, Chartered Accountants, Statutory Auditors of the Company with an unmodified opinion on the above-mentioned financial results dated November 05, 2026. Kindly take the above on record. The Board meeting commenced at 12:00 p.m. (IST) and concluded at 12:39 p.m. (IST). Thanking you, Yours faithfully, For Fermenta Biotech Limited Varadvinayak Khambete Company Secretary & Head - Legal Membership No. A33861 Encl: As above SR BCC&O LLP 12tFhl oTohrRe,u by 29S enapatMia rBga pat Dad(aWre st) ChartAecrceodu ntants Mumb�a4 i0 002 8I,n dia Tol:+292168198000 IndepeAnuddeinttRo erv'iRsee wp oorntt h Qeu artaenrdYl eyat roD atUen audSittaendd aFlionnaen cial Resuolftt hsCe o mpaPnuyr sutaotn htRe e gula3t3oi fot nh SeE B(IL isOtbilnigg aatnidDo inssc losure RequireRmeegnutlsa)2t 0i1oa5nsa,s m ,e nded ReviReewp otrot ThBeo aorfdD irectors FermeBnitoat Leicmhi ted 1.Weh avree vietwhaeecd c ompasntyaitneogmf ue nnatu dsittaendd failnoanrneec siuoalflFt esr menta BiotLeicmhi( ttehCdeo mpafnoytr"hq )eu aretnedrSe edp te3m0b2,e0 r2a 6n yde atrod atfer oAmp r0i1l, 202t6oS epte3m0b2,e0 r2 (6t hSet atemaetntta"ch)he erde wbietihsn,ug b mibtytt ehCdeo mpany purstuota hnrete quiroefRm eegnutls3a 3ot fti hoSenE (BLIi sOtbilnigga antDdii osncslR oesquurier ements) Regula2t0i1ao5san, ms e,n d(etdhL ei sRteignugl ations"). 2.ThCeo mpaMnayn'asg eimrsee nstp onfsotirhb pelr ee paroaftt hSieto ant eimnae cncto rwdiatnthch ee recogannimdte iaosnu rpermiennctli adpioldwe insnI ndian Accou3n4t{,iI nAngSd3 4S)lt natnedrairmd FinaRnecpioarlpt riensgc"ur nidbSeeerdc t1i3oo3nf t hCeo mpaAnci2te0,s1 a3sa mendreedaw,di th relervualnietss s utehde reuannddoe trha ecrc ountingg epnreiranacclcilepypil tnIee nsdd a inadi n compliwaintRchee g ul3a3to ifto hnLe i stRienggu laTthieSo tnast.e hmaebsne te anp probvyte hde CompaBnoya'orsfDd i recOtuorrre ss.p onistsio eb xiplriaect soysn clounts hiSeot na tebmaesnoetndo u r review. 3.Wec onduocutrree dv ioeftw h Set ateimnae cncto rdwainttchheS e t andoanRr edv iEenwg agements (SR2E4)1 R0e,v ioefIw n teFriinma InncfioarlmP aetrifoobnry tm heIedn depeAnuddeiontftto h rEe n tity" issbuyet dhI en stoifCt huatret Aecrceodu notfIa nndTtihsasi .ts a nrdeaqrudti hrwaeetsp laannp de rform three vtioeo wb tmaoidne raastseu raastn owc hee tthheSert ateimfser noetfem atemriisaslt atAement. revioefiw n tefriinma inncfioarlmc aotnisooifnms atksi inngq uiprriiemsao,rfp i elrysr oenssp onfsoirble finaanncdia aclc oumnatitntagen rdsa ,p playnianlgy atnidoc tahlre erv iperwo cedAu rreevsii.es w substalnetsiisnsa cloltpyhe a anna udciotn duicnta ecdc ordwaintSchte a ndoanrA dusd iatnidng conseqduoeennsote tln ya ubslt eoo btaasisnu rtahnwacetwe o ubledc ome oafaw lsalir gen imfaitctaenrts thmaitg bheit d entiianfn ai uedAdic tc.o rdwiedn ong oletyx ,p raenas usdo ipti nion. 4.Basoenod u rre vcioenwd uacsat beodnv oet,h hiancsgo mteoo uart tentthicaoatnu u sset sob elitehvaet thaec compaSntyaitnepgmr eenptia,anr c ecdo rwdiattnhhcr eee cogannimdte iaosnu rpermiennctli apildes dowinnt he afIonrdeAiscaacnio du Snttainndg{a 'rIAdnSssd' p )e cuinfdiSeeerdc t1i3oo3nft hCeo mpanies Ac2t0,1 a3sa mendreedaw,di trhe lervualinestss tuheedr eaunnoddt ehrae crc oupnrtiinncggie pnleersa lly accepitnIe ndd hiaans,o dti scltohsieen df ormraetqiuotinorb eedd i sclionts eerdom fst hLei sting Regulaitnicolntushdm,eia nngni ewnrh iicithts ob ed iscloorts heiacdtto, n taanimyna st emriisaslt atement. FoSr R CBO L CL P& ChartAecrceodu ntants ICFAiIrr meg isnturmabt3ei2ro4:n9 82E/E300003 pePro onTaomd arwal Partner MemberNsoh1.i3:p6 454 uD1:1N6: I3f,<>1i.iL�AuI'lr.2.i 1� PlaMcuem:b ai DatNeo:v em0b5e2,r0 26 SRB C& C OL LPaL, i miLtleadbP lahrttyn ewristLhhLli Pap e nNtoiA.tA yB -4318 RegOdf.f :i2 c2Ce,a maStcr eBelto',cB k3' r,Fd l oKoorl,k at0a1-67 00 FermeBnitoatL eicmhi ted CIN:L99999MH1951PLC008485 RegOdf.f Ai-c1e5:T0 h1a,On neeD ,IC Lo mplGehxo,d buRnodaMedar,j iwTahdaa(n,We e 4s0t60)1 0M,a haraIsnhdtiraa., Ferrnenta Tel:+91-22F-a6x7:9+89018-8282,- 6i7n9f8o0@9f9e9r,mEemnatiWaleb:bi sowitwtewec.:hf .ecromme,n tabiotech.com �i nL akhs STATEMOEFSN TTA NDALUONNAEU DIFTIENDA NRCEISAULFL OTTRSH QEU ARTAENRDH ALYFE AERN DESDE PTEM3B02E,0R 2 6 Standalone QuartEenrd ed HaYlefa Ern deµ YeaErn ded Sr. Particulars UnauditedU nauditedU naudited UnaUundaiutdeidt edA udited September 30, SeptemberS e3p0t,e3 m0b,e Sre pte3m0b,e rM ar3c1h, No. Jun3e02 ,0 26 2026 2025 2026 2025 2026 1 Income aR)e vefnruoeom p era(tRieoNfnoest4r e) 11,693.631 1,183.931 0,711.522 2,877.5262 ,613.394 5,025.27 b)O thienrc ome 364.92 489.66 552.79 854.58 1,436.87 2,389.89 2 TotIanlc o(mae+ b) 12,058.551 1,673.591 1,264.31 23,2743,20.5104. 264 7,415.16 3 Expenses aC) osotfm atercioanlssu( mReedNf oet6re) 3,162.12 4,485.76 4,151.28 7,647.887 ,330.291 6,656.99 b)P urchoafss teosc k-in-trade 152.47 130.19 594.41 282.66 1,130.79 1,150.05 cC)h anignie n venotffoirniiegssoh oesddts ,o ck-ainnwd-o trrka-dien -progress 724.90 (1,062.56()1 ,490.28()3 37.66)( 581.38)( 2,470.98) d)E mplobyeeneee fxiptesn se 2,080.26 2,005.15 1,872.66 4,085.413 ,769.94 7,413.83 e)Finacnocset s 373.30 253.91 258.76 627.21 569.26 1,148.44 fD)e precainaadtm ioortni seaxtpieonns e 519.83 518.61 513.42 1,038.441 ,068.15 2,093.63 g)O theexrp enses 3,169.10 3,327.95 3,286.85 6,497.056 ,414.081 3,195.70 Toteaxlp en(satego s) 10,181.989 ,659.01 9,187.101 9,840.9199 ,701.133 9,187.66 4 Profitt ab(xe2 f-o3r)e ��a1 ,876.57 2,014.58 2,077.21 3,891.154 ,349.13 8,227.50 5 Excepittieoimnnsac lo/ m e(exp(eRnesNfoeets7re) 8 &) - . - - . 696.62 6 ProaffitEtex rc eptIitoeanmnasbdl e ftora(ex4 -5) 1,876.57 2,014.58 2,077.21 3,891.154 ,349.13 8,924.12 7 Taexx pense aC)u rrteanxt �!THANE ; } 454.79 436.09 371.70 890.88 772.08 1,460.72 b)D efetrarcxeh da rge 26.42 79.91 233.72 106.33 481.88 1,035.04 � .o Tottaaelxx pe(nas+eb ) * 481.21 516.00 605.42 997.21 1,253.96 2,495.76 8 Proffoitrth p ee rioda/fytteeaa(rxr6 -7) - 1,395.36 1,498.58 1,471.79 2,893.943 ,095.17 6,428.36 9 OthCeorm prehIenncsoimvee (A)iI )t etmhswa itnl olbt er eclatsoPs riofofirLie otds s . - . - 32.68 iiI)n cotmatexh ereon - - - ,_ - (8.23) (BI)t etmhswa itbl erl e clatsoPs riofofirLie otds s (iN)ef ta viarlc uhea nignie n vesitenmq euniitnt syt rutmhernootutsgh he r 2.38 (0.68) (9.42) 1.70 (2.60) (6.68) iIin)c otmatexh ereon. (0.60) 0.17 0.59 (0.43) 0.59 1.68 Totoatlhc eorm prehlenncsoimvee/ (Loss) SIGNFEODIR D ENTIFICAT 1.I 7O 8 N (0.51) (8.83) 1.27 (2.01) 19.45 10 TotCaolm prehIenncsoifmvoteerh pee riod(/8y+e9a)r b Y 1,397.14 1,498.07 1,462.96 2,895.213 ,093.16 6,447.81 11 Paide-quupsi htaycr aep (iFtaavclae l� u5 e/p-esrh are) R,f 1,436.37 1,434.03 1,454.83 1,436.371 ,454.83 1,433.53 12 Otheeqru (ietxyc lruedvianlgru easteirvoen) 40,848.04 13 Earnpienergq su sihtayor fe5� e ac(hn aontn ualised) SRB C& C OL LP MUMBAI Earnpienergq su sihtayor fe5� e acbhe feoxrcee pittieomnsa l a) �B asic 4.86 5.23 5.05 10.09 10.61 20.43 b} �D iluted 4.77 5.13 5.01 9.90 10.54 20.27 Earnpienergq su sihtayor f�e e5a cahf teexrc epittieomnsa l a) �B asic 4.86 5.23 5.05 10.09 10.61 22.13 b) �D iluted 4.77 5.13 5.01 9.90 10.54 21.96 Seaec compannoyttieotns hg Se t [Showing first 8,000 characters — download PDF for full document]